Spyre Therapeutics, Inc. (SYRE)
NASDAQ·Healthcare·Biotechnology
$90.75
+2.29%
Mkt Cap $7.73B
Analyst Ratings
Buy
25
Hold
0
Sell
0
Price Target (22 analysts)
$97.64
Range $49.00 – $135.00
Implied Upside
+7.6%
Consensus $97.64 vs current $90.75
NASDAQ·Healthcare·Biotechnology
$90.75
+2.29%
Mkt Cap $7.73B
Buy
25
Hold
0
Sell
0
Price Target (22 analysts)
$97.64
Range $49.00 – $135.00
+7.6%
Consensus $97.64 vs current $90.75